VALNEVA (EPA:VLA) | WebDisclosure

Basculer en Français

8225	Companies
111034	Keywords
52755	Articles
60940	Press releases

Home
Companies
VALNEVA

PRESS RELEASE

published on 08/13/2024 at 07:00, 2 months 26 days ago

Valneva Reports Half Year 2024 Financial Results and Provides Corporate Updates
Valneva reports first-half 2024 financial results as total revenues reach €70.8 million with net profit of €34.0 million. Company confirms full-year guidance and updates strategic pipeline expansion

Revenues Financial Results Net Profit Valneva Strategic Pipeline
BRIEF

published on 08/06/2024 at 08:35, 3 months 2 days ago

Valneva annonce des modifications au titre du capital et des droits de vote au 31 juillet 2024

Euronext Paris Actions Biopharmaceutique Droit De Vote Valneva
BRIEF

published on 08/06/2024 at 08:35, 3 months 2 days ago

Valneva Announces Share and Voting Right Changes as of July 31, 2024

Euronext Paris Voting Rights Shares Biopharmaceutical Valneva
PRESS RELEASE

published on 08/06/2024 at 08:30, 3 months 2 days ago

VALNEVA - Déclaration d’actions et de droits de vote : 31 juillet 2024
Déclaration d'actions et de droits de vote de Valneva pour le 31 juillet 2024. Cession et passages de titres avec droits de vote double

Cession Droits De Vote Actions Valneva Double
PRESS RELEASE

published on 08/06/2024 at 08:30, 3 months 2 days ago

VALNEVA - Declaration of shares and voting rights: July 31, 2024
VALNEVA declared changes in shares and voting rights including sale, transfer, and granting of double voting rights on various dates

Voting Rights Shares Sale Transfer Valneva
BRIEF

published on 07/17/2024 at 22:05, 3 months 21 days ago

Essai de Phase 3 VALOR : Valneva et Pfizer finalisent la vaccination primaire contre la maladie de Lyme

Essai Clinique Valneva Pfizer VLA15 Lyme
BRIEF

published on 07/17/2024 at 22:05, 3 months 21 days ago

VALOR Phase 3 Trial: Valneva and Pfizer Finalize Primary Lyme Disease Vaccination

Clinical Test Valneva Pfizer VLA15 Lyme
PRESS RELEASE

published on 07/17/2024 at 22:00, 3 months 21 days ago

Phase 3 VALOR Lyme Disease Trial: Valneva and Pfizer Announce Primary Vaccination Series Completion
Phase 3 VALOR Lyme Disease Trial: Pfizer and Valneva announce completion of primary vaccination series with VLA15, progressing towards a Lyme disease vaccine

Valneva Lyme Disease Vaccine Pfizer VLA15 VALOR
PRESS RELEASE

published on 07/17/2024 at 22:00, 3 months 21 days ago

Essai de Phase 3 VALOR sur la maladie de Lyme : Valneva et Pfizer finalisent la vaccination primaire de tous les participants
Pfizer et Valneva finalisent la vaccination primaire de l'essai de Phase 3 VALOR contre la maladie de Lyme, avec VLA15. Suivi des participants pour mesurer l'incidence de la maladie

Valneva Maladie De Lyme Pfizer Phase 3 VALOR Vaccination Primaire
BRIEF

published on 06/05/2024 at 07:05, 5 months 3 days ago

Valneva annonce la mise à disposition de la documentation pour son Assemblée Générale Mixte et fait le point sur l'entreprise

Assemblée Générale Valneva Mise À Jour De L'entreprise Changements À La Direction

Accesswire

Published on 11/08/2024 at 12:00, 16 minutes ago

Fusion Energy Agreement Between RSE and BLUE LASER FUSION (USA)
Published on 11/08/2024 at 10:00, 2 hours 16 minutes ago

BluSky Carbon CEO Presents a Case for Climate Tech Optimism
Published on 11/08/2024 at 09:00, 3 hours 16 minutes ago

Greene Tweed Awarded 'Excellence in International Trade' at the 2024 East Midlands Chamber Business Awards
Published on 11/08/2024 at 07:00, 5 hours 16 minutes ago

Polaris Renewable Energy Announces Fixed Income Meetings
Published on 11/08/2024 at 03:00, 9 hours 16 minutes ago

Alset AI Appoints Wall Street Veteran and Venture Executive as President

View all ACCESSWIRE

EQS Group

Published on 11/08/2024 at 12:01, 15 minutes ago

EQS-Adhoc: Borussia Dortmund reports preliminary figures for the first quarter (Q1) of the 2024/2025 financial year
Published on 11/08/2024 at 12:01, 15 minutes ago

Original-Research: Knaus Tabbert AG (von Montega AG): Kaufen
Published on 11/08/2024 at 11:30, 46 minutes ago

Shelly Group: Invitation to unaudited 9M 2024 earnings webcast/call on 14 November 2024
Published on 11/08/2024 at 11:12, 1 hour 4 minutes ago

Original-Research: Masterflex SE (von Montega AG): Kaufen
Published on 11/08/2024 at 11:10, 1 hour 6 minutes ago

Ossiam ESG Shiller Barclays CAPE® Global Sector UCITS ETF: notice of closure

Les Echos

Published on 11/08/2024 at 12:15, 1 minute ago

Louis Hachette Group announces the publication of its Information Document for listing on Euronext Growth (Paris)
Published on 11/08/2024 at 12:15, 1 minute ago

Louis Hachette Group annonce la publication de son Document d’Information en vue de sa cotation sur Euronext Growth (Paris)
Published on 11/08/2024 at 08:00, 4 hours 16 minutes ago

DAMARTEX / Droits de vote bruts et réels 31 octobre 2024
Published on 11/07/2024 at 19:00, 17 hours 16 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/07/2024 at 19:00, 17 hours 16 minutes ago

ALTAREA : DECLARATION MENSUELLE DES OPERATIONS REALISEES PAR LA SOCIETE SUR SES PROPRES TITRES OCTOBRE 2024

View all LES ECHOS COMFI WIRE